People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Galvanize Therapeutics, Inc. | — | Biotechnology | Series C | $150.7M | $581.7M | 2015 |
| Galaxy Medical, Inc. | — | Biotechnology | Series A | $10.0M | $14.3M | 2020 |
| Galavant Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $100K | $5.5M | 2020 |
Jonathan Waldstreicher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Waldstreicher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 3 | 19 |
| David Lewis | 1 | 7 |
| ANTOINE PAPIERNIK | 1 | 6 |
| David McIntyre | 1 | 5 |
| Doug Godshall | 1 | 3 |
| Zack Scott | 1 | 3 |
| Steve Anheier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.